Dash Bio
Dash Bio provides automated bioanalysis for preclinical and clinical drug testing.
$30MSeries A
Role not disclosedFC
Freestyle Capital
Activity from announced rounds
All recorded activity
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $46M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in all activityKeebler Health
LLM-native platform that processes unstructured clinical docs to surface missed HCC coding opportunities
$16MSeries A
Role not disclosed